JNJ•benzinga•
Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study
Summary
Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high clearance rates and favorable safety.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga